Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze RDY stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RDY investment potential.

What is RDY stock price today?

Get real-time RDY stock price, historical data, and price charts on Financhill. Track RDY performance with our advanced analysis tools.

Is RDY a good investment?

Evaluate RDY investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RDY stock?

To buy RDY stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RDY?

View detailed market capitalization data and company valuation metrics for RDY on our comprehensive analysis page.

What is the P/E ratio of RDY?

Use our fundamental analysis tools to view RDY P/E ratio and compare valuation metrics with industry peers.

What are RDY earnings?

View RDY earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Dr. Reddy's Laboratories Ltd. Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

RDY
Dr. Reddy's Laboratories Ltd.

Last Price:

$14.20

Seasonality Move:

4.97%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

Dr. Reddy's Laboratories Ltd. Stock Forecast

Over the next 52 weeks, Dr. Reddy's Laboratories Ltd. has on average historically risen by 13.1% based on the past 24 years of stock performance.
Dr. Reddy's Laboratories Ltd. has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
Is Dr. Reddy's Laboratories Ltd. Stock Undervalued?

The current Dr. Reddy's Laboratories Ltd. [RDY] share price is $14.19. The Score for RDY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
RDY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Dr. Reddy's Laboratories Ltd. Stock Go Up Next Year?

Over the next 52 weeks, Dr. Reddy's Laboratories Ltd. has on average historically risen by 13.1% based on the past 24 years of stock performance.

Dr. Reddy's Laboratories Ltd. Stock Rating

Buy

Dr. Reddy's Laboratories Ltd. (RDY) is a Buy

Is Dr. Reddy's Laboratories Ltd. overpriced?

Dr. Reddy's Laboratories Ltd. has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%

Dr. Reddy's Laboratories Ltd. Stock Price History

Is RDY stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RDY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NYSE

Country:

India

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

drreddys.com

52-Week Data

52-Week High:

16.17

52-Week Low:

12.26

Prediction Charts

Market Cap:

11.8B

Price in USD:

14.19

Volume:

816.3K

Beta:

0.61

Technical Analysis

SMA50:

14.02

SMA100:

14.18

SMA200:

14.10

52-Wk Change:

-1.94%

Stock Predictions

Is Dr. Reddy's Laboratories Ltd. stock public?

Yes, Dr. Reddy's Laboratories Ltd. is a publicly traded company.
What is the Dr. Reddy's Laboratories Ltd. stock quote today?

The Dr. Reddy's Laboratories Ltd. stock price is 14.19 USD today.
How to buy Dr. Reddy's Laboratories Ltd. stock online?

You can buy Dr. Reddy's Laboratories Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	13.71	13.96	14.05	13.71
Nov-18	13.95	14.02	14.07	13.83
Nov-19	14.03	14.05	14.10	14.00
Nov-20	14.03	13.90	14.08	13.89
Nov-21	13.88	13.91	14.01	13.84
Nov-24	13.84	13.66	13.85	13.64
Nov-25	13.79	13.88	13.92	13.74
Nov-26	13.93	13.99	13.99	13.88
Nov-28	13.95	14.05	14.06	13.88
Dec-1	14.01	13.94	14.06	13.94
Dec-2	14.15	14.10	14.20	14.05
Dec-3	14.09	14.13	14.17	14.08
Dec-4	14.11	14.14	14.19	14.11
Dec-5	14.13	14.19	14.21	14.10

Dr. Reddy's Laboratories Ltd. Earnings

Dr. Reddy's Laboratories Ltd. Earnings Report: Per Share Dr. Reddy's Laboratories Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dr. Reddy's Laboratories Ltd. Forecast Revenue Growth

Dr. Reddy's Laboratories Ltd. Stock Analysis: Historical quarterly revenues per share for Dr. Reddy's Laboratories Ltd. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.13 per share.

* Dr. Reddy's Laboratories Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.